Partner Shabbi Khan was quoted in a Corporate Counsel article, “Challenges in Implementing AI Include Staffing and Knowing What to Use It for,” about the challenges legal departments face as they work to implement artificial intelligence and machine learning technology.
Khan said a lot of companies are paying top dollar to have data scientists do very specific jobs, which dissuades them from creating their own companies and stifles innovation. “It’s hard to find enough talent for a given vertical who are equipped to handle these machine learning types of environments,” he said.
One of the reasons in-house legal departments are not creating their own artificial intelligence programs is the expense, he added. “As a company your argument is that ‘we might save costs,’ but you have to spend $100,000 to find out if you’ll save anything,” he said. “It is not a low-cost implementation.”
Khan said a lot of companies are paying top dollar to have data scientists do very specific jobs, which dissuades them from creating their own companies and stifles innovation. “It’s hard to find enough talent for a given vertical who are equipped to handle these machine learning types of environments,” he said.
One of the reasons in-house legal departments are not creating their own artificial intelligence programs is the expense, he added. “As a company your argument is that ‘we might save costs,’ but you have to spend $100,000 to find out if you’ll save anything,” he said. “It is not a low-cost implementation.”
People
Related News
September 18, 2026
In the News
Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations
Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.